Dionyssiotis Yannis
Physical Medicine and Rehabilitation Clinic, University Hospital of Ioannina, Ioannina, Greece.
Eur Endocrinol. 2019 Apr;15(1):13-14. doi: 10.17925/EE.2019.15.1.13. Epub 2019 Apr 12.
In the 21st century, life expectancy has increased and consequently so has the number of elderly people. Sarcopenia is an emerging area in geriatric medicine. The European Working Group on Sarcopenia in Older People (EWGSOP) defined sarcopenia as a syndrome characterised by progressive and generalised loss of skeletal muscle mass and strength and/or physical performance, associated with a risk of adverse outcomes such as physical disability, poor quality of life, and death. Sarcopenia requires diagnostic and interventional methods in order to initiate timely and appropriate treatment. Diagnosing sarcopenia requires assessments of muscle mass, muscle strength and physical performance. Management of sarcopenia involves a variety of approaches. Nutritional and exercise interventions are strongly supported.
在21世纪,预期寿命有所增加,因此老年人的数量也随之增加。肌肉减少症是老年医学中一个新兴的领域。欧洲老年人肌肉减少症工作组(EWGSOP)将肌肉减少症定义为一种综合征,其特征是骨骼肌质量、力量和/或身体机能进行性、全身性丧失,并伴有身体残疾、生活质量差和死亡等不良后果的风险。肌肉减少症需要诊断和干预方法,以便及时开展适当的治疗。诊断肌肉减少症需要评估肌肉质量、肌肉力量和身体机能。肌肉减少症的管理涉及多种方法。营养和运动干预得到了大力支持。